CRWV Company (NASDAQ: CRWV) plans $1.80M sale and details 10b5-1 trades
Rhea-AI Filing Summary
CRWV has a planned sale of up to 25,000 shares of common stock, to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate value of $1,797,000.00 and the shares listed on NASDAQ. These are identified as Founders Shares originally dated February 25, 2019. The disclosure also lists numerous Rule 10b5-1 plan sales of common stock during June and July 2026 by Brannin McBee, Meghan Bennett and several related trusts and entities, each with specified share amounts and dollar values.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 25,000 shares
Aggregate value of planned sale: $1,797,000.00
10b5-1 sale on 07/20/2026 (Brannin McBee): 144,000 shares for $10,819,094.40
+3 more
6 metrics
Planned shares to be sold
25,000 shares
Common stock, planned sale through Morgan Stanley Smith Barney LLC Executive Financial Services
Aggregate value of planned sale
$1,797,000.00
Indicated value for 25,000 common shares to be sold
10b5-1 sale on 07/20/2026 (Brannin McBee)
144,000 shares for $10,819,094.40
Common stock sold under Rule 10b5-1 on July 20, 2026
10b5-1 sale on 06/22/2026 (Brannin McBee)
144,000 shares for $16,023,672.00
Common stock sold under Rule 10b5-1 on June 22, 2026
10b5-1 sale on 06/29/2026 (Meghan Bennett)
25,000 shares for $2,358,107.50
Common stock sold under Rule 10b5-1 on June 29, 2026
Non-plan sale on 06/30/2026 (Brannin McBee)
56,707 shares for $5,426,292.83
Common stock sale reported for June 30, 2026
Key Terms
Form 144, Founders Shares, 10b5-1 Sales, Irrevocable TR LLC, +1 more
5 terms
Form 144 regulatory
"144: Securities Information Common | Morgan Stanley Smith Barney LLC"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 Sales regulatory
"10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave."
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Irrevocable TR LLC financial
"CANIS MAJOR 2024 IRREVOCABLE TR LLC 290 W Mt. Pleasant Ave."
GRAT financial
"CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the CRWV Form 144 filing disclose about planned stock sales?
The filing shows a holder plans to sell 25,000 CRWV common shares through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate value of $1,797,000.00, and identifies the securities as Founders Shares dated February 25, 2019.
What recent Rule 10b5-1 sales of CRWV stock are reported for Brannin McBee?
Brannin McBee is reported in multiple Rule 10b5-1 sales, including 144,000 shares for $10,819,094.40 on July 20, 2026 and further blocks of 144,000 shares on several June and July 2026 dates, each with specified dollar proceeds.
Over what period does the CRWV Form 144 list prior stock sales?
The Form 144 lists prior CRWV common stock sales over roughly the past three months, including dates in May, June, and July 2026, with individual transactions showing precise share counts and total dollar amounts for each sale.
What kind of CRWV securities are being reported in this Form 144?
All transactions involve CRWV common stock. The planned sale covers 25,000 Founders Shares dated February 25, 2019, and the past three-month activity section lists additional common stock sales under Rule 10b5-1 trading plans by named individuals and related entities.